Home › Exclusive- India's Lupin, U.S. firms weigh bids for GSK's mature drugs: sources
 

Keywords :   


Exclusive- India's Lupin, U.S. firms weigh bids for GSK's mature drugs: sources

2014-07-22 22:02:47| Biotech - Topix.net

Assuming a multiple of between two and three times those sales, the assets on the block could fetch between $3.5 billion and $5.0 billion , the sources said.

Tags: sources exclusive drugs firms

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.07Murdoch Netflix rival to launch in UK
02.07Hurricane Beryl Forecast Discussion Number 14
02.07Hurricane Beryl Graphics
02.07Hurricane Beryl Wind Speed Probabilities Number 14
02.07Hurricane Beryl Public Advisory Number 14
02.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Hurricane Beryl Forecast Advisory Number 14
02.07Atlantic Tropical Weather Outlook
More »